Avian pneumovirus (APV) or turkey rhinotracheitis virus (TRTV) is an important respiratory pathogen of domesticated poultry in many countries in Europe, Africa, and Asia. Until recently, the United States was considered free of APV. In late 1996, an atypical upper respiratory tract infection appeared in turkey flocks in Colorado and shortly thereafter in turkey flocks in Minnesota. An avian pneumovirus (APV-US) that was serologically distinct from the previously described TRTV was isolated as the primary cause of the new syndrome. The nucleotide sequence of a fragment of the APV-US fusion gene was determined and used to develop a polymerase chain reaction-based assay that specifically detects APV-US viral nucleic acid sequences in RNA extracts of tracheal swabs and turbinate homogenates. The assay is highly sensitive in that it can detect Ͻ0.01 TCID 50 of APV. The availability of this assay enables the rapid and accurate determination of APV-US in infected poultry flocks.
In mid-1996, a respiratory disease with atypical clinical signs and presentation was observed in turkey flocks in Colorado. 23 The main characteristics of this new syndrome were an abrupt onset, a highly contagious nature, and high flock morbidity (frequently approaching 100%). 4 The clinical signs associated with this disease included depression, gasping, moist tracheal rales, coughing, submandibular edema, swelling of infraorbital sinuses, foamy ocular discharge, and excessive mucus in external nares. In uncomplicated cases, affected birds recovered in approximately 2 weeks, and the overall flock mortality was low (ϳ3%). However, in some turkey flocks mortality exceeded 50% because of secondary bacterial infections. Initial efforts to identify the etiologic agent were unsuccessful; none of the previously recognized pathogens were recovered from diseased flocks. After substantial investigative efforts, in February 1997 researchers at the National Veterinary Services Laboratories (NVSL), Ames, Iowa, reported the isolation of a novel avian pneumovirus (APV-US) from affected turkey flocks. 23 This was the first report of APV isolation in the United States; until recently, North America was considered free of APV infections. 21 Within a few months after the initial description of the disease in Colorado, the appearance of APV infection was recorded in commercial turkey flocks in Minnesota and in a few counties in North and South Dakota.
Initial serologic studies at the NVSL indicated that the isolated virus (termed the Colorado isolate) was distinct but antigenically related to the virus that causes turkey rhinotracheitis (TRT) and swollen head syndrome (SHS) in other parts of the world. 23 Previous investigations have identified 2 related but distinct subgroups (A and B) of TRT virus (TRTV) on the basis of genetic variation in the attachment (G) protein gene. 13 The successful use of fusion (F) and G genebased polymerase chain reaction (PCR) assays for the detection of non-US APVs has previously been reported. 8, 11, 13, 18 A PCR assay based on the nucleotide sequence of a fragment of the F protein gene for the detection of this novel APV in clinical specimens is described herein. This report also includes a discussion of the genetic relationship of this emerging virus with non-US APVs.
Materials and methods
Virus isolate. The APV (Colorado isolate) was initially obtained from the NVSL as sixth passage in chicken embryo fibroblast (CEF) cells and was further passaged twice in CEF cells. The cell cultures were incubated at 37 C in the presence of 5% CO 2 for 3-5 days and were harvested by 2 freeze-thaw cycles after the appearance of moderate cytopathic effects (syncytium formation). The cell debris was removed by centrifugation at 3,000 ϫ g for 10 min at 4 C, and the supernatant was aliquoted and stored at Ϫ80 C. Viral nucleic acid extracts from 2 additional APV isolates, TRTV strain UK/CVL/14/1 17 and Hungarian89 19 were also obtained from the NVSL.
Processing of clinical samples. Clinical samples (intact turkey heads and tracheal/esophageal swabs) were collected from affected turkey farms or were received at the University of Minnesota Veterinary Diagnostic Laboratory for diagnosis of APV infection. Tracheal swabs were collected from birds with different stages of clinical signs ranging from severe to mild. Swabs from birds within the same pen without any apparent clinical manifestation of infection were ). Nucleotide identities with the APV-US sequence are indicated by a ·, and polymorphic sites among all 3 groups are represented with nucleotide base pair at the corresponding polymorphic site. B. Phylogenetic relationships of APV-US with previously described APV and human respiratory syncytial virus (HRSV) isolates. A dendrogram depicts phylogenetic relationships among APV-US and non-US APVs and HRSV isolates representing subgroup A and subgroup B for the 536-bp fragment of the F gene. A bootstrap tree was generated with the computer program PAUP 4.0. 24 The dendrogram was constructed using the nearest-neighbour interchange option with branch swapping and 1,000 bootstrap replications, using the HRSV sequence as the outgroup. The percentage of 1,000 bootstrap trees that supported the clustering is indicated to the right of each node. also included in the pool of test samples. The PCR samples were processed by mixing the transport medium with an equal volume (2 ml) of sterile Hanks balanced salt solution (HBSS) containing antibiotics (300 units/ml pencillin, 300 g/ml streptomycin, 50 g/ml gentamicin, 150 g/ml neomycin, and 1 g/ml fungizol). Intact turkey heads were processed by aseptic removal of the turbinate tissue mass and thorough homogenization with sterile HBSS containing antibiotics. Material recovered from 2 turkey heads was pooled for each PCR sample. The cell-free supernatant from both types of specimens was collected after centrifugation of the homogenate at 3,000 ϫ g for 30 min at 4 C. The supernatant was stored at Ϫ80 C.
RNA extraction and reverse transcription PCR. Viral RNA from cell-free supernatant of virus-infected cell cultures and clinical samples was extracted using a commercial kit a according to the manufacturer's instructions. Negative control RNA was extracted from uninfected cell culture supernatant and was similarly processed.
The cDNA synthesis reaction was performed in a final volume of 25 l. For each cDNA reaction, 5 l of extracted RNA (containing 200-300 ng of total RNA) was mixed with a final concentration of 1ϫ PCR buffer II, 5 mM MgCl 2 , 800 nM each dNTP (dATP, dCTP, dGTP), 1,600 nM dUTP, 20 units of RNAse inhibitor, 20 units of murine leukemia virus reverse transcriptase, and 2 mM random hexamer oligonucleotides. b Diethyl pyrocarbonate (DEPC)-treated water was added to each reaction to achieve a final volume of 25 l and reverse transcription (RT) was performed by incubating the samples at 22 C for 10 min followed by an incubation at 42 C for 15 min. The reaction was stopped by heating to 92 C for 10 min, followed by snap cooling to 5 C for 5 min. The primers used in the PCR reaction were 1F (5Ј-GATCAAGTGGCTAAGGAAAG) and 1R (5Ј-CCAT-CATAAACACCAATCAA) and were designed based on the previously described sequence for the F gene of TRTV-UK3B/85 18 (GenBank accession number D00850) ( Fig. 1 ). The PCR mix consisted of 5 l of the cDNA prepared in the RT step and a final concentration of 1ϫ PCR buffer II, 5 mM MgCl 2 , 2.5 units of AmpliTaq DNA polymerase, b 200 nM of each primer, and DEPC water to a final volume of 25 l. After initial denaturation of the cDNA template at 94 C for 2 min, 30 cycles of 94 C for 1 min, 60 C for 1 min, and 72 C for 2 min were performed before the final extension of the product at 72 C for 10 min. The PCR products were resolved by electrophoresis in 1.2% agarose gels and stained with ethidium bromide. The PCR products of APV-US (Colorado isolate) and other APVs (subgroup A and subgroup B) were excised from the agarose gel and cleaned with a commercial DNA cleaning kit. c The cleaned PCR products were sequenced in both orientations using a primer-walking strategy after cloning into a plasmid vector. d All sequence reactions were performed at the University of Minnesota Advanced Genetic Analysis Center (AGAC) using automated DNA sequencers. e Development of an APV-US-specific RT-PCR. On the basis of the partial sequence information of the F gene of APV-US, a second set of oligonucleotide primers, 2F (5Ј-GCTGTGAAT-GATCTCAAGGAC) and 2R (5Ј-TTCCTTCTGACCATTG-CC), was designed for the specific detection of the APV-US isolates (Fig. 1 ). All other PCR conditions were the same as described above. The specificity of the assay was tested by using viral RNA from APV-US (Colorado), TRTV-UK14/1 (subgroup A), and TRTV-Hungarian89 (subgroup B) virus. In addition, the specificity of the PCR assay was tested against a panel of avian viral and bacterial agents that are likely to be encountered in the avian respiratory tract. The panel included Newcastle disease virus A9 and B1 strains, avian influenza virus (H4N5), infectious bronchitis virus (ARK strain), infectious bursal disease virus (Lukert strain), avian reovirus, avian encephlitis virus, Pasteurella multocida, and Escherichia coli. The sensitivity of the PCR assay was determined by using RNA extracted from serial 10-fold dilutions of APV-US containing a known quantity (starting with 56 TCID 50 ) of the virus. All specificity and sensitivity assays were repeated at least twice at different time points and from different template preparations to verify the reproducibility of the assay system. A total of 49 clinical samples (respiratory tract homogenates and tracheal/esophageal swabs) from turkey flocks in Minnesota with documented clinical and serologic status were also tested with this primer set (2F and 2R). The PCR products from 3 clinical samples were sequenced for confirmation of the identity of the amplified product.
Sequence analysis. The DNA sequences were assembled, aligned, and analyzed with the EDITSEQ, MEGALIGN (using the CLUSTAL V method), 10 and SEQMAN computer programs. f Phylogenetic analysis of the aligned sequences was performed with PAUP 4.02b. 24 The dendrogram was constructed using the nearest-neighbor interchange option with branch swapping and 1,000 bootstrap replications.
The number of synonymous changes per synonymous site (d s ) and coding changes per nonsynonymous site (d n ) in coding regions of the F gene of APVs were calculated by the unweighted method. 20
Results
Sequence analysis. The partial nucleotide sequence information of the F gene fragment (Fig. 1a ) of APV-US obtained in this study was submitted to a public genetic database (GenBank accession number AF176593). The analysis of the nucleotide sequences revealed that the F gene of the APV-US isolate was distinct from all previously described APVs based on searches of other public DNA databases (nonredundant GenBank, EMBL, DDBJ, PDB). The nucleotide sequence of the 536-bp fragment of the F gene of APV-US corresponds to nucleotides 271-807 of the previously described sequence of the F gene of TRTV-UK/ 3B isolate (D00850). Comparative nucleotide alignment (Fig. 1a ) of the sequences revealed the nucleotide sequence identity of this F gene fragment to be 72% and 65% (82% and 75% at the amino acid level) with APV subgroups A and B, respectively. In comparison, the nucleotide and amino acid sequence identities between APV subgroups A and B are 72% and 90%, respectively (Fig. 1a) . These results suggest that the APV-US isolate represents a novel (third) subgroup of APVs (Fig. 1b) .
Pattern of nucleotide substitutions. Alignment of nucleotide sequences of this fragment of the F gene from APV-US revealed a total of 157 and 184 polymorphic sites compared with APV subgroups A and B, respectively. Consistent with this finding, the total (x Ϯ SD) nucleotide diversity () between APV-US and that of subgroups A and B was 0.281 Ϯ 0.0190 and 0.330 Ϯ 0.0199, respectively. In contrast, the nucleotide sequence diversity between subgroups A and B is slightly less at 0.241 Ϯ 0.0180.
To determine the pattern of nucleotide substitutions, the rates of synonymous and nonsynonymous nucleotide substitution between APV-US and the 2 previously described subgroups of APVs were determined. 14, 20 Pairwise comparisons showed that the d n /d s ratio between APV-US and the corresponding region in the F gene in APV-UK (subgroup A) was 0.109. The same comparison between APV-US and APV subgroup B could not be made because the high level of variation made it beyond detection limits of the program.
Specificity and sensitivity of PCR. The primers 2F and 2R designed for the specific detection of APV-US infections showed amplification of a 280-bp specific fragment of the F gene from APV-US isolate but not from genetic material from TRTV-UK or the Hungar-ian89 strains (Fig. 2a ). The same primers (2F and 2R) and reaction conditions also specifically amplified the 280-bp fragment of the F gene from clinical samples recovered from turkey flocks in Minnesota (Fig. 2b) . The primers showed no amplification from cDNA/ DNA prepared from a panel of other avian viral or bacterial pathogens or from the no-template controls. The PCR assay detected virus-specific templates in virus samples diluted to the equivalent of as low as 0.01 TCID 50 (Fig. 3 ).
Discussion
Traditionally, virus isolation (VI) in cell cultures is considered the ''gold standard'' in the diagnosis of viral infections. However, because of several factors including difficulty in in vitro propagation of APV, 6, 18 failure to recover the virus from clinical samples collected Ͼ7 days after infection, 5 and increased labor and time involved in achieving final results, VI is not considered the method of choice for routine diagnosis of APV infections. 6, 7 Alternative assays such as indirect immunofluorescence assay and enzyme linked immunosorbent assay (ELISA) previously described for direct detection of APV and other pneumoviral infections are faster than VI but have lower relative sensitivity. 2, 9, 25 The RT-PCR assays for the detection of APV infection in other parts of the world have previously been reported to be highly sensitive and specific. 3, 4, 8, 11, 12 Others have described the F and G gene-based primers used in their PCR assays as being universal oligonucleotides for the detection of APV infections. 11, 13 Additional researchers have reported some discrepancies in the application of these F and G gene-based primers and have described higher sensitivity for the N genebased PCR for the detection of APV infections. 3 The application of nested PCR assays has also been described as more sensitive for the detection of non-US APVs. 11, 16 However, the nested PCR has the disadvantage of requiring an additional step prior to obtaining results and also has an increased risk of false-positive results due to carryover DNA contamination. 8 Another approach tested for the detection of non-US APVs includes the use of digoxigenin-labeled (F gene based) primers for PCR and then immunochemiluminescent Southern blotting of the PCR product. 8, 25 This method has the advantage of increased sensitivity and also reduced risk of false-positive reactions. More recently, an M gene-based PCR assay has been described for the detection of APV-US infection. 1 However, information regarding the specificity and detection limits of this assay are not available.
The assay described here is an F gene-based PCR that is specific and highly sensitive for the detection of APV-US infection. In preliminary studies, APV-US nucleic acid was detectable up to 12 days after the appearance of signs of APV infection in turkey flocks (Dar, Goyal, and Kapur, unpublished data). These data are consistent with the detection of TRTV/APV for a similar duration using F gene-specific primers. 16 Further, the use of this PCR assay results in the detection of APV-US nucleic acid in clinical samples considerably before the detection of serum antibodies by ELISA (Dar, Goyal, and Kapur, unpublished observations).
The presence of 157 and 184 polymorphic sites in the fragment of the F gene of APV-US when compared with the corresponding regions of the F gene of APV subgroups A and B, respectively, is higher than the difference (136) observed between the corresponding regions of the F gene of APV subgroup A and APV subgroup B.
The d n /d s ratio was determined to examine the selective forces driving the evolution of the F gene. The ratio between APV-US and APV subgroup A at 0.109 suggests the occurrence of purifying selection to maintain the primary structure of the F protein. 15 Taken together with the results of the phylogenetic reconstructions using parsimony, the data also suggest that 1) there has been an increased positive selection in this region of the F gene of APV-US; 2) the APV-US lineage diverged at an earlier time point from a common APV ancestor than did the APV A and B lineages from each other; and/or 3) APV-US is the ancestor of APV subgroup A and subgroup B lineages. At this time, it is not possible to determine which, if any, of these hypotheses is correct. However, these results are consistent with what has previously been reported for the M protein genes of the APV-US and non-US APVs. 22 There are several unanswered questions regarding APV-US and the disease it causes in US poultry flocks. First, the provenance of this virus is unknown, and how this genetically divergent lineage of APV-US reached the United States is also unclear. Second, the vectors involved in the spread of the disease and the natural reservoirs and hosts of APV-US infection are unknown. Third, the extent of genetic diversity (if any) among APV-US isolates has not yet been determined. A comprehensive research program to answer these questions has recently been initiated, and the results of these investigations will provide valuable insight into the biology and molecular epidemiology of this important emerging avian pathogen. The use of specific and sensitive molecular assays for the detection of APV infections will help answer some of these questions.
